MeiraGTx Holdings plc

MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. The company's pipeline includes programs across several therapeutic areas, including inherited retinal diseases, salivary gland diseases, and neurological diseases. MeiraGTx utilizes its gene therapy platform to design and develop novel therapies aimed at addressing the underlying genetic causes of these conditions. By delivering functional genes into targeted cells, the company aims to restore normal cellular function and provide long-lasting therapeutic benefits. MeiraGTx is committed to advancing its innovative gene therapy programs through clinical development and ultimately delivering transformative treatments to patients in need. The company operates in the biotechnology and pharmaceutical sectors, contributing to advancements in genetic medicine.